Abstract
Use of fentanyl test strips (FTS) to test illicit drugs has been shown to be an effective harm-reduction tool for raising awareness of fentanyl risks, increased self-efficacy to prevent overdose, and safer use behavior changes. From March to June 2020, a total of 6 Massachusetts municipal police departments piloted FTS kit distribution during post–overdose outreach visits, community outreach, and related programming. The Police Assisted Addiction and Recovery Initiative developed the kits, trained departments, and oversaw implementation. The pilot evaluation involved site observations, process measures, and interviews with staff and kit recipients. For every kit distributed, there was approximately 1 health or support service or referral provided; 320 kits were distributed. Key themes from interviews were conceptualizing FTS as a tool, collaborations, and adaptations. Police departments that partnered with community programs amplified project reach. FTS distribution is a simple yet powerful tool that community providers and police can offer alongside linkage to care services and engagement with people who use drugs and their family and friends.
Keywords: community outreach, fentanyl, fentanyl test strips, harm reduction, police
The drug supply is in enormous flux, with illicitly manufactured fentanyl (IMF) creating a deadly environment for people who use drugs (PWUD). IMF is sold as heroin and counterfeit prescription opioids and found as contaminant in cocaine and other drugs.1 PWUD report relying on smell, taste, color, and word of mouth to determine fentanyl presence, but these approaches are not foolproof and detection errors come at great risk.2 Use of immunoassay fentanyl test strips (FTS) by PWUD has been shown to increase fentanyl awareness and is associated with greater self-efficacy to prevent overdose and safer use behavior changes.3–7 The easy-to-use, inexpensive FTS require minimal sample preparation and rapidly produce valid results.8 Many syringe service programs (SSPs) and other community initiatives distribute FTS.3,9 Although public safety outreach efforts offer naloxone, provide referrals to treatment and mental health care, and extend other local resources,10 there are no known examples of FTS distribution by police. We conducted a pilot to evaluate implementation and feasibility of a police-led FTS kit distribution program in 6 Massachusetts municipalities.
Methods
The Massachusetts Department of Public Health oversaw a multisite FTS pilot project that was independently evaluated by Brandeis researchers and implemented by the Police Assisted Addiction and Recovery Initiative (PAARI), a nonprofit organization that provides training, support, and resources regarding nonarrest pathways to treatment and recovery to police departments. Municipal police departments were invited to apply to pilot FTS distribution, aligning with the Massachusetts Harm Reduction Commission recommendations.11 To pilot departments, PAARI provided trainings, conducted regular check-ins, and fostered a learning community through peer-enhanced communications and ongoing supports. A series of technical assistance videos on how to distribute kits and fentanyl safety awareness were created and shared publicly (https://paariusa.org/rollcallvideos/).
Data collected included monthly reports of kits distributed, manner of distribution (via outreach, other mechanism), and services provided or referrals made at kit distribution. Mid-pilot, small cups and instructions to dilute suspected methamphetamine samples were added to kits to improve test validity12 along with masks and hand sanitizer for COVID-19 safety. Midpoint and final convenings gathered agencies to share successes and challenges.
To track implementation and evaluate intervention feasibility, a mixed-methods approach was undertaken. Methods included analysis of monthly service reports, site observations, confidential interviews with recipients and program implementers, and an anonymous exit survey of piloting agencies.
A semistructured interview guide for pilot partners and FTS recipients covered a range of topics: experiences supporting public health and public safety efforts, with overdose, and in providing harm-reduction tools; perceptions and familiarity with FTS; implementation and distribution experiences; and COVID-19 adaptations and impacts. Interview topics for FTS recipients also covered the following: experience with overdose, harm reduction, interactions with community agencies; familiarity in receiving and using FTS; peer education; and secondary distribution. A Textual Analysis framework was applied to identify, contextualize, and report the most saliently semantic themes.13
Finally, all participating agencies were invited to complete an anonymous online exit survey that assessed their opinions and knowledge regarding FTS, syringes, naloxone, and Massachusetts laws relevant to FTS. Descriptive statistics were used to analyze all survey data and services reported.
Results
After an application period, 6 pilot police departments were selected on the basis of geographic considerations and overdose burden. Unpredictably, the project timeline collided with the start of the COVID-19 pandemic (see Supplemental Digital Content Figure 1, available at http://links.lww.com/JPHMP/A999): from April to June, 320 kits were distributed, leading to provision of 318 referrals or follow-up services.
Three implementation models emerged. Three departments employed a police department–led model of distribution that relied upon community outreach by officers and civilian staff and involved community partners in no or limited ways. Two departments employed a community program–led distribution model by working with existing community partners, such as SSPs, treatment programs, and hospitals, to assist in distribution; police supported but had little direct involvement in this model. One department adopted a hybrid model of police- and community-led kit distribution, wherein police fostered new collaborations with local treatment programs to augment the pilot's reach. The highest volume of kits and services provided was from community programs that received kits from police department partners. There were 97, 115, and 108 kits, respectively, distributed through the 3 models, and 65, 206, and 47 associated referrals and services provided (Table). Most services or referrals provided encompassed harm-reduction materials (eg, syringes, naloxone), drug treatment, counseling services, wound care, food, or housing. For every 1 kit distributed, there was approximately 1 service or referral provided.
TABLE 1. Fentanyl Test Strip Kits Distributed and Services and Referrals Provided by Each of 3 Main Models of Kit Distribution.
Police Department–Led Model | Community Program–Led Model | Hybrid Police- and Community-Led Model | |
---|---|---|---|
Number of fentanyl test strip kits distributed | 97 | 115 | 108 |
Number of referrals/services | 65 | 206 | 47 |
Types of referrals/services | |||
Provision of harm-reduction servicesa | 27 | 142 | 0 |
Drug treatment | 13 | 19 | 20 |
Counseling | 6 | 5 | 16 |
Wound care | 4 | 13 | 0 |
Meals/food | 3 | 10 | 0 |
Housing | 9 | 3 | 0 |
Medical | 0 | 5 | 0 |
Financial | 0 | 3 | 0 |
HIV/HCV testing | 3 | 0 | 11 |
Identification card support | 0 | 3 | 0 |
Legal support | 0 | 2 | 0 |
Drug-checking services | 0 | 1 | 0 |
Abbreviations: HCV, hepatitis C virus; HIV, human immunodeficiency virus.
aProvision of harm-reduction services included provision of overdose education and naloxone distribution, sterile syringes, and safe use supplies. More than 1 referral or service may have been provided.
Twenty-two interviews were conducted with recipients (n = 2) and implementers (n = 20), from which we identified 3 themes around implementation and feasibility: conceptualizing FTS as a tool, collaborations, and adaptations.
First, data suggested that police departments were willing to distribute FTS kits and found them useful to promote safety conversation:
It's the engagement. It's to get there and talk to ‘em. I have ... no skepticism now. I just see it as an engagement program. I mean, if somebody is taking the time to test, you know, that's great. You know? Maybe they won't take a pill that they think is.... Adderall and have it be pressed fentanyl, you know? If that's what they do, that's what they do, that's great. It'll probably save their life. But, you know ... as an engagement tool, I think it's great if you can stop and talk to somebody for a couple of minutes. And even if they throw the strip away behind your back when you walk away, then at least you talked to them and you maybe might have planted that seed.
Others saw utility in supporting engagement in preventive and harm-reducing behaviors for the person at risk and how FTS could be tools for caregivers they interact with too:
So, one mom was scared. She goes, “I don't know if I wanna give it to him,” 'cause now I'm giving him permission to use drugs. And she says, “You know, walk that through. What if he buys drugs and he passes away? That's gonna weigh heavy on you.” And she said, “You're right. Like, I can't control his outcome in regards to using or not using, but I can give him a prevention method which is handing him this kit.”
Second, linked to the pilot, we observed a strengthening of existing partnerships between community programs and police departments and the creation of new ones. Police officers were acutely aware of the value of relationships with community agencies, as one officer stated:
I tell you, I couldn't do what we do without the groups that we work with ... I mean, I think I said it on the last Zoom call, but they've been outstanding. They have done basically all the leg work for us and, you know, they are the ones that have the connections in the community. And they have been the ones that have, kind of, like, introduced us into that community.
Some community partners became involved in the intervention because they had existing relationships with the police, while other community connections evolved serendipitously: “A [police officer] in the Community Impact Unit asked if we were interested in providing these to people that we see inpatient or wherever I see them and we jumped on the idea.”
Third, adaptations to the kit and distribution approaches emerged. Both community partners and police departments innovated social media content (Facebook, Instagram, Twitter) to share about FTS availability in the community and were subsequently contacted requesting FTS delivery or pickup locations (during COVID-19 restrictions). Another adaptation requested the creation of trainings, materials, and kit instructions in other languages, especially Spanish. After the pilot end, Spanish language materials and videos were created for dissemination.
Finally, findings from the exit survey (n = 23 of 33; 70% response rate) suggested that participation in the pilot led to further interest in provision of other harm-reduction supplies. Respondents indicated interest in starting distribution of naloxone (2 police departments), sterile syringes (1 hospital, 1 police department), and personal syringe disposal units (4 police departments, 1 community partner). A majority agreed that they now consider FTS (89%), naloxone (94%), and sterile syringes (83%) as positive engagement and harm-reduction tools for PWUD. The only consistently named barrier from community partners was confusion over the legal status of FTS and concerns around their possession and distribution.
Implications for Policy & Practice
FTS are an easy-to-use intervention that community partners and police can offer alongside linkage to treatment and recovery services.
Police departments that partnered with or arranged for community partner programs to lead provision of FTS directly to people at risk of fentanyl use had greater subsequent distribution of harm-reduction supplies, referrals for medical and social support services, and other care connections than programs that relied only upon police-led FTS distribution points.
It is important to provide tools that assist people in detecting fentanyl so that they can better care for themselves and others and reduce possible harms of fentanyl.
Discussion and Conclusion
In 90 days and amidst pandemic stay-at-home orders and suspension of all nonessential services, FTS pilot partners distributed hundreds of kits, leading directly to referrals for supporting services such as drug treatment, wound care, food, and housing. Regardless of the pandemic, PWUD and their social networks needed services and FTS pilot partners strived to meet those needs. In so doing, the intended goals to raise awareness of local supporting services and create additional pathways and linkages to services were met in the 6 municipalities.
Findings suggest that FTS, distributed through community agencies or partnerships with police, can be one, promising engagement tool set within the broader landscape of overdose awareness and as a complement to more comprehensive strategies for harm reduction, treatment, and recovery.
Clear need for FTS, financial support, legal clarity, and pilot examples can facilitate dissemination of public health innovations. As of April 2021, federal guidance explicitly permits FTS purchase with health and social service funds. A recent legal analysis explained the legality of possessing and distributing drug-checking equipment such as FTS in Massachusetts and other states.14 This pilot demonstrates several models of collaborations between public health and public safety entities to bridge access to lifesaving tools such as FTS. Additional study across more geographies is warranted and may provide further insights.
Supplementary Material
Footnotes
Funding from the Centers for Disease Control and Prevention (NU17CE002724; PI: Ruiz) to the Massachusetts Department of Public Health, Bureau of Substance Addiction Services supported this research.
The authors thank Sarah Ruiz and Brittni Reilly of the Massachusetts Department of Public Health, Bureau of Substance Addiction Services, for their assistance in implementing this project. The authors are grateful to the participants, harm-reduction and community organizations, municipalities, and police departments that took part in this study.
The authors declare no conflicts of interest.
Human participant compliance statement: All procedures were reviewed and approved by Brandeis University and the Massachusetts Department of Public Health institutional review boards.
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal's Web site (http://www.JPHMP.com).
Contributor Information
Rebecca Olson, Email: beccaolson@brandeis.edu.
Patricia Case, Email: zalafa@gmail.com.
Wilson R. Palacios, Email: Wilson_Palacios@uml.edu.
Allie Hunter, Email: alliehunter02@gmail.com.
Vanessa Lopes-McCoy, Email: vanessa@paariusa.org.
Traci C. Green, Email: tracigreen@brandeis.edu.
References
- 1.O'Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700—10 states, July-December 2016. MMWR Morb Mortal Wkly Rep. 2017;66(43):1197–1202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Goldman JE, Krieger MS, Buxton JA, et al. Suspected involvement of fentanyl in prior overdoses and engagement in harm reduction practices among young adults who use drugs. Subst Abus. 2019;40(4):519–526. [DOI] [PubMed] [Google Scholar]
- 3.Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE. Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2019;63:122–128. [DOI] [PubMed] [Google Scholar]
- 4.Krieger MS, Yedinak JL, Buxton JA, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018;15(1):7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Glick JL, Christensen T, Park JN, McKenzie M, Green TC, Sherman SG. Stakeholder perspectives on implementing fentanyl drug checking: results from a multi-site study. Drug Alcohol Depend. 2019;194:527–532. [DOI] [PubMed] [Google Scholar]
- 6.Rouhani S, Park JN, Morales KB, Green TC, Sherman SG. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence. Harm Reduct J. 2019;16(1):39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BDL, Green TC. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. Int J Drug Policy. 2019;68:46–53. [DOI] [PubMed] [Google Scholar]
- 8.Green TC, Park JN, Gilbert M, et al. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. Int J Drug Policy. 2020;77:102661. [DOI] [PubMed] [Google Scholar]
- 9.Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug Alcohol Depend. 2018;190:242–245. [DOI] [PubMed] [Google Scholar]
- 10.Formica SW, Waye KM, Benintendi AO, et al. Characteristics of post-overdose public health-public safety outreach in Massachusetts. Drug Alcohol Depend. 2021;219:108499. [DOI] [PubMed] [Google Scholar]
- 11.The Harm Reduction Commission. The Harm Reduction Commission Report. Boston, MA: Commonwealth of Massachusetts; 2019. [Google Scholar]
- 12.Lockwood TE, Vervoordt A, Lieberman M. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips. Harm Reduct J. 2021;18(1):30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. [Google Scholar]
- 14.Davis CS, Lieberman AJ, O'Kelley-Bangsberg M. Legality of drug checking equipment in the United States: a systematic legal analysis. Drug Alcohol Depend. 2022;234:109425. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.